AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $49.5 million versus the consensus estimate of $59.5 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.